Specificity of cGMP binding to a purified cGMP-stimulated phosphodiesterase from bovine adrenal tissue
- 1 May 1985
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 149 (1) , 59-65
- https://doi.org/10.1111/j.1432-1033.1985.tb08893.x
Abstract
The binding of [3H]cGMP to purified bovine adrenal cGMP-stimulated phosphodiesterase was measured by Millipore filtration on cellulose ester filter. [3H]cGMP-binding activity was enhanced when the assay was terminated in buffer containing 70% of saturated ammonium sulfate to dilute the enzyme and wash the filters. The cGMP-binding activity was co-purified with the phosphodiesterase activity. The binding of [3H]cGMP to purified enzyme was measured in the presence or absence of the phosphodiesterase inhibitor, 1-methyl-3-isobutylxanthine. 1-Methyl-3-isobutylxanthine showed linear competitive inhibition with respect to cGMP as substrate in the phosphodiesterase reaction but stimulated the [3H]cGMP-binding activity in the binding assay. The stimulatory effect appeared not to be the result of preservation from [3H]cGMP hydrolysis; no cGMP phosphodiesterase activity was measured under the cGMP-binding assay conditions in the absence or presence of the inhibitor. Half-maximal stimulation by 1-methyl-3-isobutylxanthine occurred in the 5-7 .mu.M concentration range. The specificity of binding of [3H]cGMP was investigated by adding increasing concentration of unlabeled analogs of cAMP and cGMP. The binding of [3H]cGMP (50 nM) was displaced by unlabeled cGMP and cAMP with the following potency: 50% displacement was reached at the 0.1 .mu.M cGMP range and only at 5-fold higher cAMP concentration. A comparative series of analogs (e.g., 5''-amino-5''-deoxyguanosine 3'',5''-monophosphate and 3''-amino-3''-deoxyguanosine 3'',5''-monophosphate) showed that the potencies of stimulation of cAMP phosphodiesterase activity parallels displacement curves or [3H]cGMP binding to purified enzyme with no correlation with phosphodiesterase inhibition sequences. The cGMP-binding activity is directly related to the non-catalytic (allosteric) cGMP-binidng site.This publication has 37 references indexed in Scilit:
- Specificity of Cyclic GMP Activation of a Multi-substrate Cyclic Nucleotide Phosphodiesterase from Rat LiverEuropean Journal of Biochemistry, 2005
- Characterization of phosphodiesterase catalytic sites by means of cyclic nucleotide derivativesEuropean Journal of Biochemistry, 1983
- The involvement of a calmodulin-dependent phosphodiesterase in the negative control of carbamylcholine on cyclic AMP levels in dog thyroid slicesFEBS Letters, 1983
- Identification and properties of cyclic nucleotide phosphodiesterasesMolecular and Cellular Endocrinology, 1982
- Paradoxical stimulation by 1‐methyl‐3‐isobutylxanthine of rat liver cyclic AMP phosphodiesterase activityFEBS Letters, 1982
- Aminonucleoside, X. Über die Synthese von 3′‐Amino‐3′‐desoxyguanosin, 3′‐Amino‐3′‐desoxyguanosin‐5′‐monophosphat und seinem 3′,5′‐CyclophosphatEuropean Journal of Organic Chemistry, 1982
- Activation of cyclic AMP-dependent protein kinases I and II by cyclic 3′,5′-phosphates of 9-β-D-ribofuranosylpurine and 1-β-D-ribofuranosylbenzimidazoleBiochemical and Biophysical Research Communications, 1980
- Characteristics of a new binding protein distinct from the kinase for guanosine 3′:5′-monophosphate in rat plateletsBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Synthese des 3′‐Amido‐3′‐desoxyadenosin‐3′,5′‐cyclophosphatsAngewandte Chemie, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970